Viral Polypeptides and Methods

The invention is directed to polypeptides and polypeptide fragments from HIV- 1 envelope (Env) proteins following the characterisation of Env structures from environments where HIV isolates expose conserved neutralisation- sensitive Env structures. There is provided a polypeptide being all or a fragment of an HIV-1 envelope protein from a transmission strain of HIV-1, the polypeptide having neutralisation sensitive epitopes that are accessible.

Patents:
WO 2,010,031,113

Inventor(s): PURCELL DAMIAN [AU]; CENTER ROBERT [AU]; REDDY SHARMILA MOHANA RAMA [AU]

Type of Offer: Sale



Next Patent »
« More Medical Patents

Share on      


CrowdSell Your Patent